Catalyst Wire Dossier Catalyst Wire Dossier

AFF004A

· Affiris AG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AFF004A, covering 2013-12-11 to 2013-12-11. Get the full timeline:

Most recent: Clinical Trial Update: Observational Follow-up Extension Study of AFF002 and AFF004A in Patients With Alzheimer's Disease

See pricing